Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
31.40
-1.63 (-4.93%)
At close: Aug 20, 2026, 4:00 PM EDT
31.15
-0.25 (-0.80%)
After-hours: Aug 20, 2026, 7:30 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $2.03 billion as of August 20, 2026. Its market cap has increased by 99.97% in one year.
Market Cap
2.03B
Enterprise Value
1.67B
1-Year Change
99.97%
Ranking
Category
Stock Price
$31.40
ChartMarket Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $2.03B, an increase of 151.86%. That is a compound annual growth rate of 13.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 2.03B | 11.76% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.19B |
| Generate Biomedicines | 2.18B |
| Palvella Therapeutics | 2.16B |
| Aurinia Pharmaceuticals | 2.15B |
| Biohaven | 2.14B |
| Agios Pharmaceuticals | 2.10B |
| Taysha Gene Therapies | 2.10B |
| Sarepta Therapeutics | 2.08B |